<html>
<head>PUBMED IDs for FTNS</head>
<body bgcolor='#C5F0F2'><h1>FTNS</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10973259/'>Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium.</a> September 6  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11590545/'>Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.</a> October 9  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11776386/'>Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions.</a> January 5  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/11918549/'>Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders.</a> March 29  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/11935325/'>Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene.</a> April 6  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12649151/'>Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome.</a> March 22  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14560660/'>[May-Hegglin anomaly--from genome research to clinical laboratory].</a> October 17  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/18925516/'>High-resolution melting analysis for detection of MYH9 mutations.</a> October 18  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19227191/'>[May-Hegglin anomaly: past and present--novel diagnostic test and new concept of the disease].</a> April 8  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19557653/'>Clinical manifestation and molecular genetic characterization of MYH9 disorders.</a> October 29  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19557645/'>S-phase fraction as response marker in patients with chronic myeloid leukemia.</a> September 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20200500/'>Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease.</a> December 14  2010<br></body></html>
